[Oxyprothepin decanoate in maintenance therapy of schizophrenia--a double-blind, standardized controlled study].
Filip
V
V
Faltus
F
F
Hanáková
S
S
Janecková
E
E
Raboch
J
J
Dobiásová
A
A
Karen
P
P
Posmurová
M
M
D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003988:Dibenzothiepins / Q000031:analogs & derivatives / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D005476:Fluphenazine / Q000031:analogs & derivatives / Q000627:therapeutic use; D049690:History, Ancient; D006801:Humans; D008297:Male; D012559:Schizophrenia / Q000188:drug therapy*
D014150:Antipsychotic Agents; D003988:Dibenzothiepins; C011825:fluphenazine depot; C025022:oxyprothepine decanoate; D005476:Fluphenazine
Oxyprothepin dekanoát v udrzovací lécbĕ schizofrenie--dvojitĕ slepá, standardem kontrolovaná studie.